Oscar G. Bukstein

10.5k total citations · 2 hit papers
147 papers, 6.8k citations indexed

About

Oscar G. Bukstein is a scholar working on Clinical Psychology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Oscar G. Bukstein has authored 147 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Clinical Psychology, 88 papers in Psychiatry and Mental health and 36 papers in Epidemiology. Recurrent topics in Oscar G. Bukstein's work include Child and Adolescent Psychosocial and Emotional Development (86 papers), Attention Deficit Hyperactivity Disorder (80 papers) and Substance Abuse Treatment and Outcomes (36 papers). Oscar G. Bukstein is often cited by papers focused on Child and Adolescent Psychosocial and Emotional Development (86 papers), Attention Deficit Hyperactivity Disorder (80 papers) and Substance Abuse Treatment and Outcomes (36 papers). Oscar G. Bukstein collaborates with scholars based in United States, Canada and Brazil. Oscar G. Bukstein's co-authors include Yifrah Kaminer, Duncan B. Clark, William E. Pelham, David A. Brent, Jack R. Cornelius, Ralph E. Tarter, David J. Kolko, Ron Stall, Kevin M. King and Michael P. Marshal and has published in prestigious journals such as American Journal of Psychiatry, PEDIATRICS and Journal of Consulting and Clinical Psychology.

In The Last Decade

Oscar G. Bukstein

144 papers receiving 6.4k citations

Hit Papers

Sexual orientation and adolescent substance use: a meta‐a... 2008 2026 2014 2020 2008 2022 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oscar G. Bukstein United States 48 3.7k 3.1k 1.5k 1.1k 1.0k 147 6.8k
Wendy Reich United States 40 4.1k 1.1× 2.8k 0.9× 958 0.6× 2.2k 2.1× 575 0.6× 67 7.5k
Prudence W. Fisher United States 34 7.6k 2.1× 3.2k 1.0× 503 0.3× 1.4k 1.3× 1.3k 1.2× 71 10.0k
Catherine Stanger United States 38 2.7k 0.7× 838 0.3× 631 0.4× 730 0.7× 869 0.8× 100 4.8k
Héctor Bird United States 42 6.4k 1.7× 2.2k 0.7× 489 0.3× 796 0.7× 1.3k 1.2× 129 8.2k
Manfred Laucht Germany 46 2.8k 0.7× 1.1k 0.4× 594 0.4× 1.0k 1.0× 735 0.7× 207 6.3k
Kelly Posner United States 31 4.3k 1.2× 2.9k 0.9× 365 0.2× 904 0.8× 1.3k 1.2× 43 7.0k
Maritza Rubio‐Stipec United States 35 3.6k 1.0× 1.6k 0.5× 561 0.4× 477 0.4× 910 0.9× 63 5.2k
Brooke S. G. Molina United States 54 5.7k 1.6× 7.7k 2.5× 1.2k 0.8× 3.1k 2.9× 468 0.5× 190 10.7k
John F. Curry United States 34 5.2k 1.4× 2.3k 0.7× 286 0.2× 1.1k 1.0× 1.4k 1.4× 110 7.1k
Joan Rosenbaum Asarnow United States 49 7.1k 1.9× 2.2k 0.7× 362 0.2× 635 0.6× 1.7k 1.7× 149 9.1k

Countries citing papers authored by Oscar G. Bukstein

Since Specialization
Citations

This map shows the geographic impact of Oscar G. Bukstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar G. Bukstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar G. Bukstein more than expected).

Fields of papers citing papers by Oscar G. Bukstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar G. Bukstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar G. Bukstein. The network helps show where Oscar G. Bukstein may publish in the future.

Co-authorship network of co-authors of Oscar G. Bukstein

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar G. Bukstein. A scholar is included among the top collaborators of Oscar G. Bukstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar G. Bukstein. Oscar G. Bukstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walter, Heather J., Oscar G. Bukstein, A. Reese Abright, et al.. (2020). Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. Journal of the American Academy of Child & Adolescent Psychiatry. 59(10). 1107–1124. 143 indexed citations
2.
Findling, Robert L., Lisa Townsend, Nicole V. Brown, et al.. (2017). The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders. Journal of Child and Adolescent Psychopharmacology. 27(1). 52–65. 22 indexed citations
3.
Barterian, Justin A., L. Eugene Arnold, Nicole V. Brown, et al.. (2017). Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings. Journal of the American Academy of Child & Adolescent Psychiatry. 56(12). 1026–1033. 7 indexed citations
4.
Farmer, Cristan, Jeffery N. Epstein, Robert L. Findling, et al.. (2016). Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory. Journal of Child and Adolescent Psychopharmacology. 27(2). 117–124. 8 indexed citations
5.
Farmer, Cristan, Nicole V. Brown, Kenneth D. Gadow, et al.. (2015). Comorbid Symptomatology Moderates Response to Risperidone, Stimulant, and Parent Training in Children with Severe Aggression, Disruptive Behavior Disorder, and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 25(3). 213–224. 27 indexed citations
6.
Arnold, L. Eugene, Kenneth D. Gadow, Cristan Farmer, et al.. (2015). Comorbid Anxiety and Social Avoidance in Treatment of Severe Childhood Aggression: Response to Adding Risperidone to Stimulant and Parent Training; Mediation of Disruptive Symptom Response. Journal of Child and Adolescent Psychopharmacology. 25(3). 203–212. 13 indexed citations
7.
Townsend, Lisa, Jayne Schneider, Cristan Farmer, et al.. (2015). Participant Satisfaction in a Study of Stimulant, Parent Training, and Risperidone in Children with Severe Physical Aggression. Journal of Child and Adolescent Psychopharmacology. 25(3). 225–233. 7 indexed citations
8.
Cutler, Andrew J., Matthew Brams, Oscar G. Bukstein, et al.. (2014). Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 53(10). 1092–1101. 19 indexed citations
9.
Pearson, Deborah A., Cynthia W. Santos, Michael G. Aman, et al.. (2013). Effects of Extended Release Methylphenidate Treatment on Ratings of Attention-Deficit/Hyperactivity Disorder (ADHD) and Associated Behavior in Children with Autism Spectrum Disorders and ADHD Symptoms. Journal of Child and Adolescent Psychopharmacology. 23(5). 337–351. 80 indexed citations
10.
Bukstein, Oscar G.. (2012). Committee on Quality Issues. 4 indexed citations
11.
Cornelius, Jack R., Antoine Douaihy, Oscar G. Bukstein, et al.. (2011). Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. Addictive Behaviors. 36(8). 843–848. 46 indexed citations
12.
Bukstein, Oscar G.. (2011). AACAP Committee on Quality Issues. 8 indexed citations
13.
Cornelius, Jack R., Oscar G. Bukstein, Antoine Douaihy, et al.. (2010). Double-blind fluoxetine trial in comorbid MDD–CUD youth and young adults. Drug and Alcohol Dependence. 112(1-2). 39–45. 81 indexed citations
14.
Cannon, Michael J., et al.. (2009). Effects of Clonidine and Methylphenidate on Family Quality of Life in Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 19(5). 511–517. 22 indexed citations
15.
Axelson, David, et al.. (2009). Pilot study assessing negative consequences among adolescents with bipolar and substance use disorders. Bipolar Disorders. 11. 30–30. 1 indexed citations
16.
Cornelius, Jack R., Oscar G. Bukstein, David Wood, et al.. (2009). Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addictive Behaviors. 34(10). 905–909. 60 indexed citations
17.
Marshal, Michael P., Mark Friedman, Ron Stall, et al.. (2008). Sexual orientation and adolescent substance use: a meta‐analysis and methodological review*. Addiction. 103(4). 546–556. 727 indexed citations breakdown →
18.
McGough, James J., Keith McBurnett, Oscar G. Bukstein, et al.. (2006). Once-Daily OROS ® Methylphenidate Is Safe and Well Tolerated in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 16(3). 351–356. 31 indexed citations
19.
Cornelius, Jack R., Duncan B. Clark, Oscar G. Bukstein, et al.. (2005). Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: A review. Addictive Behaviors. 30(9). 1824–1833. 36 indexed citations
20.
Kelly, Thomas M., John E. Donovan, Jack R. Cornelius, et al.. (2003). Psychiatric disorders among older adolescents treated in emergency departments on weekends: a comparison with a matched community sample.. Journal of Studies on Alcohol. 64(5). 616–622. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026